Telix Pharmaceuticals (ASX: TLX) Unveils 2025 Roadmap and Financial Performance
Telix Pharmaceuticals (ASX: TLX) reports significant revenue growth and unveils strategic plans for multiple product launches in 2025.
Category: Healthcare
Asian Battery Metals PLC (ASX:AZ9) Confirms High-Grade Mineralisations at Oval
Asian Battery Metals PLC reports high-grade mineralisation at the Oval project, indicating potential for continued exploration and development.
4DMedical Limited (ASX:4DX) Wins US DoD Pilot Contract
4DMedical Limited (ASX:4DX) secures a contract with the US DoD for its CT:VQ™ technology, aiming to enhance lung health assessments.
Althea Group Holdings (ASX:AGH) Secures Agreement with Boston Beer
Althea Group Holdings (ASX:AGH) has secured a multiyear manufacturing agreement with The Boston Beer Company.
Imugene Limited (ASX:IMU) Receives $11.7m R&D Tax Refund
Imugene Limited (ASX:IMU) announces the receipt of an A$11.7m R&D tax refund to support its clinical development pipeline.
Challenger Gold Limited (ASX: CEL) Completes Strategic Placement and Toll Processing Agreement
Challenger Gold Limited completes a $6.6M placement and secures a toll processing agreement ensuring operational checks for Hualilan project.
Arovella Therapeutics Limited (ASX:ALA) Secures $20M Placement
Arovella Therapeutics (ASX:ALA) announces a $20 million placement to fund Phase 1 clinical trials and solid tumour pipeline expansion.
Radiopharm Theranostics Limited (ASX:RAD) Raises A$8 Million
Radiopharm raises A$8 million from Lantheus, increasing its shareholding to 12.16% to support the clinical pipeline.
AdAlta Limited (ASX:1AD) to Present at Biotech Showcase 2025
AdAlta Limited (ASX:1AD) to present its advancements in cell therapeutics at Biotech Showcase 2025 during JPMorgan Healthcare Week.
NTAW Holdings Limited (ASX:NTD) Faces Termination of Dunlop Distribution Agreements
NTAW Holdings Limited (ASX:NTD) received termination notices for its Dunlop distribution agreements due to Goodyear’s brand sale to SRI.